Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03189862 · ClinicalTrials.gov registry record · NA

A PATH (Promoting Activity and Trajectories of Health) for Children

A NA study, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
299
Enrollment target

NCT03189862: Completed NA study, sponsored by University of Michigan.

NCT03189862 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 299 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03189862, a NA study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
299 participants
Enrollment target

Study Summary

Physical inactivity in children is a major public health risk factor and a health objective for the nation. This study aims to investigate the short- and long-term effects of a movement and physical activity program - the Children Health and Motor Programs (CHAMP) on motor competence, perceived motor competence, and physical activity. A secondary aim of this project (i.e., Science of Behavior Change Administrative Supplement) is to examine the immediate (pre- to post-test) effects of the CHAMP intervention on self-regulation and associations between self-regulation and changes in motor competence, perceived motor competence, and physical activity. The long term goal is to provide evidence-based movement experiences during the early childhood years that promote and contribute to overall healthy growth and development.

Primary Outcome

Motor competence process measures will be scored using the Test of Gross Motor Development-3rd Edition; scores for the two subscales - locomotor (score range: 0-46) \& object-control (score range: 0-54) will be reported as raw scores for each skill \& an overall score total MC score which is created by summing the subscales( score range: 0 (low motor competence) - 100 (high motor competence)). Locomotor, object control, and total raw scores will be used for data analyses when appropriate. All sc

Interventions

  • BEHAVIORAL Motor Skills Intervention

Trial Details

FieldValue
Enrollment Target 299 participants
Start Date 2017-09-11
Est. Completion 2021-11-01
Phase NA
University of Michigan

1,327 total trials

What the finished NCT03189862 record still lists

NCT03189862 is an interventional study that assigns participants to a tested intervention. The registered 299 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).

The record links to 0 conditions, and to 1 intervention - of which Motor Skills Intervention is the first listed.

NCT03189862 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03189862 about?

NCT03189862 is a clinical study titled "A PATH (Promoting Activity and Trajectories of Health) for Children". Physical inactivity in children is a major public health risk factor and a health objective for the nation. This study aims to investigate the short- and long-term effects of a movement and physical activity program - the Children Health and Motor Programs (CHAMP) on motor competence, perceived moto...

What is the current status of trial NCT03189862?

This trial is currently completed. It is a NA study. The enrollment target is 299 participants. The study started on 2017-09-11. Estimated completion is 2021-11-01.

What interventions are being tested in trial NCT03189862?

The interventions under investigation include: Motor Skills Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03189862?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03189862's enrollment target sits among peer trials

299 371st of 2000 higher than 1,630 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03189862, the US trial registry maintained by the National Library of Medicine. NCT03189862 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.